Functional Assay
Coomassie blue staining of BAFF, Soluble (human) (60-mer) (AG-40B-0112) under reducing conditions (shows the size of the monomer).
Functional Assay
Size fractionation on Superdex-200. A. BAFF (60-mer) was submitted to size fractionation on a Superdex 200 gel filtration column. The peak indicated with dotted red lines (60-mer) was isolated and processed to obtain purified BAFF, Soluble (human) (60-mer) (AG-40B-0112). Elution position of MW markers are indicated on the top of the figure. B. For comparison, elution profile of the related product BAFF, Soluble (human) (3-mer).
Functional Assay
BAFF, Soluble (human) (60-mer) (AG-40B-0112) binds and activates BCMA receptor. Method: Jurkat T cells expressing a BCMA:Fas chimerical receptor (containing a extracellular domain of human BCMA and the intracellular domain of human Fas) were exposed for 16h to various concentrations of BAFF, Soluble (human) (60-mer). Cell viability was measured with the PMS/MTS assay.
Functional Assay
Coomassie blue staining of BAFF, Soluble (human) (60-mer) (AG-40B-0112) under reducing conditions (shows the size of the monomer).
Functional Assay
Size fractionation on Superdex-200. A. BAFF (60-mer) was submitted to size fractionation on a Superdex 200 gel filtration column. The peak indicated with dotted red lines (60-mer) was isolated and processed to obtain purified BAFF, Soluble (human) (60-mer) (AG-40B-0112). Elution position of MW markers are indicated on the top of the figure. B. For comparison, elution profile of the related product BAFF, Soluble (human) (3-mer).
Functional Assay
BAFF, Soluble (human) (60-mer) (AG-40B-0112) binds and activates BCMA receptor. Method: Jurkat T cells expressing a BCMA:Fas chimerical receptor (containing a extracellular domain of human BCMA and the intracellular domain of human Fas) were exposed for 16h to various concentrations of BAFF, Soluble (human) (60-mer). Cell viability was measured with the PMS/MTS assay.
Functional Assay
Coomassie blue staining of BAFF, Soluble (human) (60-mer) (AG-40B-0112) under reducing conditions (shows the size of the monomer).
Functional Assay
Size fractionation on Superdex-200. A. BAFF (60-mer) was submitted to size fractionation on a Superdex 200 gel filtration column. The peak indicated with dotted red lines (60-mer) was isolated and processed to obtain purified BAFF, Soluble (human) (60-mer) (AG-40B-0112). Elution position of MW markers are indicated on the top of the figure. B. For comparison, elution profile of the related product BAFF, Soluble (human) (3-mer).
Functional Assay
BAFF, Soluble (human) (60-mer) (AG-40B-0112) binds and activates BCMA receptor. Method: Jurkat T cells expressing a BCMA:Fas chimerical receptor (containing a extracellular domain of human BCMA and the intracellular domain of human Fas) were exposed for 16h to various concentrations of BAFF, Soluble (human) (60-mer). Cell viability was measured with the PMS/MTS assay.
Functional Assay
Coomassie blue staining of BAFF, Soluble (human) (60-mer) (AG-40B-0112) under reducing conditions (shows the size of the monomer).
Functional Assay
Size fractionation on Superdex-200. A. BAFF (60-mer) was submitted to size fractionation on a Superdex 200 gel filtration column. The peak indicated with dotted red lines (60-mer) was isolated and processed to obtain purified BAFF, Soluble (human) (60-mer) (AG-40B-0112). Elution position of MW markers are indicated on the top of the figure. B. For comparison, elution profile of the related product BAFF, Soluble (human) (3-mer).
Functional Assay
BAFF, Soluble (human) (60-mer) (AG-40B-0112) binds and activates BCMA receptor. Method: Jurkat T cells expressing a BCMA:Fas chimerical receptor (containing a extracellular domain of human BCMA and the intracellular domain of human Fas) were exposed for 16h to various concentrations of BAFF, Soluble (human) (60-mer). Cell viability was measured with the PMS/MTS assay.